HealthCare Global Enterprises gained 2.62% to Rs 213.20 at 15:16 IST on BSE after a bulk deal of 13.06 lakh shares was executed on the scrip at Rs 215.10 per share at 10:42 IST on BSE.
Meanwhile, the S&P BSE Sensex was down 95.49 points or 0.34% at 27,981.51
Bulk deal boosted volume on the scrip. On BSE, so far 15.45 lakh shares were traded in the counter as against average daily volume of 4,937 shares in the past one quarter. The stock hit a high of Rs 227.30 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 210 so far during the day. The stock had hit a record low of Rs 167 on 24 June 2016. The stock had outperformed the market over the past one month till 19 August 2016, rising 6.98% compared with 1.32% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 14.78% as against Sensex's 10.97% rise.
The small-cap company has equity capital of Rs 85.08 crore. Face value per share is Rs 10.
HealthCare Global Enterprises (HGEL) reported consolidated net profit of Rs 4.98 crore in Q1 June 2016 as compared with net loss of Rs 0.50 crore in Q1 June 2015. Net sales rose 18.58% to Rs 166.80 crore in Q1 June 2016 over Q1 June 2015.
HGEL is a provider of speciality healthcare in India, focused on cancer and fertility. Under the HCG brand, the company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB. HGEL also provides fertility treatment under the Milann brand.
Powered by Capital Market - Live News